Ticker

Analyst Price Targets — R

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
July 29, 2026 9:36 amBrandon OglenskiBarclays$300.00$260.13TheFly Ryder price target raised to $300 from $290 at Barclays
July 24, 2026 2:35 pmRavi ShankerMorgan Stanley$320.00$270.56TheFly Ryder price target raised to $320 from $280 at Morgan Stanley
July 24, 2026 12:30 pmSusquehanna$310.00$264.25TheFly Ryder price target raised to $310 from $290 at Susquehanna
July 24, 2026 10:46 amWells Fargo$300.00$267.91TheFly Ryder price target raised to $300 from $290 at Wells Fargo
July 6, 2026 12:07 pmMorgan Stanley$280.00$265.39TheFly Ryder price target raised to $280 from $263 at Morgan Stanley
June 25, 2026 11:21 amBrandon OglenskiBarclays$290.00$261.01TheFly Ryder price target raised to $290 from $250 at Barclays
June 17, 2026 10:14 amRobert W. Baird$290.00$274.66TheFly Ryder price target raised to $290 from $253 at Baird
June 5, 2026 10:30 amRobert SalmonWells Fargo$290.00$264.96TheFly Ryder price target raised to $290 from $260 at Wells Fargo
April 24, 2026 11:12 amJordan AlligerGoldman Sachs$245.00$242.59TheFly Ryder price target raised to $245 from $219 at Goldman Sachs
April 24, 2026 10:43 amDaniel MooreRobert W. Baird$253.00$242.59TheFly Ryder price target raised to $253 from $202 at Baird

Latest News for R

Ryder System Still Has Fuel In The Tank

Ryder System, Inc. remains a Buy as management drives revenue and profitability growth, with shares still trading at low multiples. Strategic focus on value-added services and shifting revenue mix toward SCS and DTS segments has doubled R's EPS and improved cash flow. FMS segment's ChoiceLease and SelectCare businesses offset rental softness, while fleet right-sizing and used-vehicle sales boost margins.

Seeking Alpha • Aug 31, 2026
Theralase(R) Releases Q2 2026 Financial Statements

Theralase(R) Provides Updates on its Phase II Bladder Cancer Clinical Study and Oncology Pipeline Toronto, Ontario--(Newsfile Corp. - August 28, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancers,…

Newsfile Corp • Aug 28, 2026
Smith-Midland Awarded $2.2M SlenderWall(R) Coast Guard Project

MIDLAND, VA / ACCESS Newswire / August 26, 2026 / Smith-Midland Corporation (NASDAQ:SMID), a leading manufacturer of innovative precast concrete products for transportation, infrastructure, and building construction, has been awarded a $2.2 million contract to manufacture and supply its SlenderWall® architectural precast wall system for the new U.S. Coast Guard Clinic and Visitors Center in Charleston, South…

Accesswire • Aug 26, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for R.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top